CAD 0.47
(-2.08%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 40.11 Million CAD | 12.95% |
2022 | 35.51 Million CAD | 57.08% |
2021 | 22.61 Million CAD | 140.88% |
2020 | 9.38 Million CAD | 0.0% |
2019 | - CAD | -100.0% |
2018 | 2.02 Million CAD | 129.42% |
2017 | 884.36 Thousand CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 12.1 Million CAD | 36.17% |
2024 Q1 | 8.89 Million CAD | -11.03% |
2023 Q4 | 9.99 Million CAD | -0.49% |
2023 Q2 | 11.28 Million CAD | 28.2% |
2023 FY | 40.11 Million CAD | 12.95% |
2023 Q1 | 8.79 Million CAD | -19.94% |
2023 Q3 | 10.04 Million CAD | -10.99% |
2022 Q2 | 8.83 Million CAD | 71.61% |
2022 Q3 | 10.54 Million CAD | 19.34% |
2022 FY | 35.51 Million CAD | 57.08% |
2022 Q1 | 5.14 Million CAD | -24.46% |
2022 Q4 | 10.99 Million CAD | 4.26% |
2021 FY | 22.61 Million CAD | 140.88% |
2021 Q4 | 6.81 Million CAD | -3.88% |
2021 Q3 | 7.09 Million CAD | 54.29% |
2021 Q2 | 4.59 Million CAD | 11.8% |
2021 Q1 | 4.11 Million CAD | -13.91% |
2020 Q3 | 3.16 Million CAD | 219.23% |
2020 Q2 | 992 Thousand CAD | 118.48% |
2020 FY | 9.38 Million CAD | 0.0% |
2020 Q1 | 454.04 Thousand CAD | 0.0% |
2020 Q4 | 4.77 Million CAD | 50.77% |
2019 FY | - CAD | -100.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q1 | - CAD | -100.0% |
2018 Q4 | 84.06 Thousand CAD | -88.85% |
2018 FY | 2.02 Million CAD | 129.42% |
2018 Q1 | 374.44 Thousand CAD | 45.21% |
2018 Q2 | 461.35 Thousand CAD | 23.21% |
2018 Q3 | 753.87 Thousand CAD | 63.41% |
2017 FY | 884.36 Thousand CAD | 0.0% |
2017 Q4 | 257.86 Thousand CAD | 7.41% |
2017 Q3 | 240.07 Thousand CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -15638.37% |
CanadaBis Capital Inc. | 22.22 Million CAD | -80.522% |
Decibel Cannabis Company Inc. | 115.95 Million CAD | 65.404% |
Delivra Health Brands Inc. | 12.37 Million CAD | -224.095% |
Entourage Health Corp. | 40.71 Million CAD | 1.465% |
Lifeist Wellness Inc. | 21.65 Million CAD | -85.211% |
Cannara Biotech Inc. | 57.26 Million CAD | 29.94% |
Medicure Inc. | 21.69 Million CAD | -84.92% |
PharmaCielo Ltd. | 1.54 Million CAD | -2502.011% |
BioSyent Inc. | 31.59 Million CAD | -26.99% |
Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |